SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 37 filers reported holding SINOVAC BIOTECH LTD in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $157,000 | +68.8% | 26,662 | +70.0% | 0.04% | +90.9% |
| Q3 2016 | $93,000 | -36.3% | 15,683 | -36.4% | 0.02% | -18.5% |
| Q2 2016 | $146,000 | +73.8% | 24,650 | +86.8% | 0.03% | +125.0% |
| Q1 2016 | $84,000 | +47.4% | 13,199 | +21.3% | 0.01% | +140.0% |
| Q4 2014 | $57,000 | -86.7% | 10,881 | -87.8% | 0.01% | -86.5% |
| Q3 2014 | $429,000 | -22.3% | 89,178 | -8.9% | 0.04% | -14.0% |
| Q2 2014 | $552,000 | +78.1% | 97,837 | +127.2% | 0.04% | +115.0% |
| Q1 2014 | $310,000 | +46.9% | 43,059 | +25.0% | 0.02% | +100.0% |
| Q4 2013 | $211,000 | -32.2% | 34,458 | -33.6% | 0.01% | -28.6% |
| Q3 2013 | $311,000 | +62.0% | 51,925 | +6.2% | 0.01% | +75.0% |
| Q2 2013 | $192,000 | – | 48,914 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,500,000 | 6.32% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.21% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.72% |
| Yorktown Management & Research Co Inc | 74,893 | $485,000 | 0.63% |
| Skandinaviska Enskilda Banken AB (publ) | 40,000 | $259,000 | 0.00% |
| Renaissance Technologies | 2,375,841 | $1,537,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,687 | $11,000 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $55,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $27,000 | 0.00% |